Supplementary data for "Vulvovaginal involvement in Stevens-Johnson syndrome/toxic epidermal necrolysis: A retrospective review at a tertiary care center (2016-2024)"

Name: Supplementary data for "Vulvovaginal involvement in Stevens-Johnson syndrome/toxic epidermal necrolysis: A retrospective review at a tertiary care center (2016-2024)"
Creator: Beatrix Thompson
Published: 2025-08-21T21:26:17.776Z
Keywords: Medical Dermatology, Vulvar Skin Disease

Thompson, Beatrix; Baker, Natalie; Corey, Sydney; Peacker, Bryan; Braun, Natalie; Ebriani, Joseph; Westmeijer, Mike; EL Banna, Ghida; Sheng-Kai Ma, Kevin; Hoang, Mai; DeWane, Madeline; Trinidad, John; Stephens, Michael; Chen, Steven

doi:10.17632/97xrvcbm29.1

Supplementary data for "Vulvovaginal involvement in Stevens-Johnson syndrome/toxic epidermal necrolysis: A retrospective review at a tertiary care center (2016-2024)"

Published: 21 August 2025| Version 1 | DOI: 10.17632/97xrvcbm29.1

Contributors:

Beatrix Thompson, Natalie Baker, Sydney Corey, Bryan Peacker, Natalie Braun, Joseph Ebriani, Mike Westmeijer, Ghida EL Banna, Kevin Sheng-Kai Ma, Mai Hoang, Madeline DeWane, John Trinidad, Michael Stephens, Steven Chen

Description

This retrospective review was conducted by querying the Research Patient Data Registry for patients hospitalized in the Mass General Brigham system with Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) from 1/1/2016 to 4/30/2024 using the International Classification of Diseases Tenth Revision billing codes L51.1-L51.3. Data were collected via manual chart review. Patients with female sex, evidence of SJS/TEN documented by dermatology, and a skin biopsy consistent with SJS/TEN were included. The suspected drug culprits for sixty-three patients with SJS/TEN are listed in Supplementary Table 1.

Supplementary data for "Vulvovaginal involvement in Stevens-Johnson syndrome/toxic epidermal necrolysis: A retrospective review at a tertiary care center (2016-2024)"

Description

Files

Categories

Licence